Over the past century, ATCC has played a pivotal role in advancing cancer research by providing high-quality, authenticated biological materials to the scientific community. As the number of cancer diagnoses increases every year, supporting groundbreaking cancer research remains a top priority for ATCC. This month’s 100 for 100 blog post explores some of the items in ATCC’s ever-growing cancer portfolio. Whether it’s reliable primary cells or seemingly unrelated bacteria strains, ATCC looks forward to the next 100 years of providing researchers with products that can change the course of cancer research.